Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Heterogeneity in access to clinical trials for innovative hemophilia treatments: a call for global equity

Department of Clinical Medicine and Surgery, Federico II University, Naples
Department of Haematology, Ege University Faculty of Medicine, Children’s Hospital, Izmir
Faculty of Medicine of Comenius University and University Hospital, National Hemophilia Center, Department of Hematology and Transfusion Medicine, Bratislava
Department of Medicine III, University Hospital, Ludwig-Maximillan University, Munich
Bohn Epidemiology, LLC, Boston, MA
Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Ontario
Department of Clinical Haematology, Haemato-Oncology and Bone Marrow Transplant Unit, Christian Medical College, Ludhiana
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan
Ludwig-Maximilians University (LMU) Rudolf Marx Stiftung Munich, München
Division of Hematology/Oncology, Icahn School of Medicine, Mount Sinai, New York, NY
Haematologica Early view Oct 1, 2026 https://doi.org/10.3324/haematol.2026.301652

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2026.301652
 
Published
2026-10-01
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
111
PDF Downloads
71
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online